Trial Profile

COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 06 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Enoxaparin sodium (Primary)
Indications COVID 2019 infections; Severe acute respiratory syndrome; Thrombosis; Venous thromboembolism
Focus Adverse reactions
Acronyms COVAC-TP

Most Recent Events

29 Apr 2022 Results published in the Pediatrics
19 Jul 2021 Status changed from recruiting to completed.
23 Jul 2020 Planned primary completion date changed from 15 Sep 2022 to 1 Sep 2022.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com